Kayo Tanaka - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kayo Tanaka

Showing results (61-70 of 75) with videos related to

Pageof 8

Sort By:

Cells|July 2, 2021

Carboxylated Poly-l-Lysine as a Macromolecular Cryoprotective Agent Enables the Development of Defined and Xeno-Free Human Sperm Cryopreservation ReagentsHiroki Takeuchi, Mikiko Nishioka, Tadashi Maezawa, et al.

The Tohoku Journal of Experimental Medicine|September 11, 2024

Clinical Characteristics of the Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS)Mizuki Yamaguchi, Sho Takakura, Hiroaki Tanaka, et al.

Medicina (Kaunas, Lithuania)|May 27, 2023

Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth RestrictionMakoto Tsuji, Shintaro Maki, Naosuke Enomoto, et al.

The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|November 19, 2019

Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trialFumi Furuhashi, Hiroaki Tanaka, Shintaro Maki, et al.

Analysis of preventability of malignancy-related maternal death from the nationwide registration system of maternal deaths in JapanShinji Katsuragi, Hiroaki Tanaka, Junichi Hasegawa, et al.

The Journal of Obstetrics and Gynaecology Research|January 26, 2018

Management of pregnancy complicated with intracranial arteriovenous malformationShinji Katsuragi, Jun Yoshimatsu, Hiroaki Tanaka, et al.

Iscience|November 11, 2024

Impacts of low birthweight on kidney development and intergenerational growth of the offspringAkiyo Sekimoto, Yoko Takaso, Haruka Saruyama, et al.

Journal of Clinical Medicine|June 19, 2019

Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II TrialShintaro Maki, Hiroaki Tanaka, Makoto Tsuji, et al.

American Journal of Hypertension|October 10, 2017

Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant MiceKento Yoshikawa, Takashi Umekawa, Shintaro Maki, et al.

International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 8, 2026

Effects of descending aortic occlusion for massive obstetric hemorrhage: Nationwide analysis of maternal death in JapanMakoto Aoki, Soichiro Obata, Manabu Ogoyama, et al.